Literature DB >> 29680973

Iatrogenic atrial septal defect: reassurance or inquisitiveness.

Niyada Naksuk1, Samuel J Asirvatham2,3.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29680973     DOI: 10.1007/s10840-018-0369-4

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


× No keyword cloud information.
  29 in total

1.  Persistence of atrial septal defect after cryoballoon ablation of atrial fibrillation.

Authors:  Edmond M Cronin; Patrick Collier; Oussama M Wazni; Brian P Griffin; Wael A Jaber; Walid I Saliba
Journal:  J Am Coll Cardiol       Date:  2013-07-31       Impact factor: 24.094

2.  One Year Incidence of Atrial Septal Defect after PV Isolation: A Comparison Between Conventional Radiofrequency and Cryoballoon Ablation.

Authors:  Giacomo Mugnai; Juan Sieira; Giuseppe Ciconte; Marta Soriano Hervas; Ghazala Irfan; Yukio Saitoh; Burak Hünük; Erwin Ströker; Vedran Velagic; Kristel Wauters; Claudio Tondo; Giulio Molon; Carlo De Asmundis; Pedro Brugada; Gian-Battista Chierchia
Journal:  Pacing Clin Electrophysiol       Date:  2015-06-12       Impact factor: 1.976

3.  Hemodynamically significant atrial septal defect after atrial fibrillation ablation: A hole to remember.

Authors:  Mian Atif Yousuf; Sulsal Haq; Robert E O'Donnell; Mehran Attari
Journal:  Heart Rhythm       Date:  2015-04-28       Impact factor: 6.343

4.  Prevalence and echocardiographic features of iatrogenic atrial septal defect after catheter-based mitral valve repair with the MitraClip system.

Authors:  Thomas Smith; Patrick McGinty; William Bommer; Reginald I Low; Scott Lim; Peter Fail; Jason H Rogers
Journal:  Catheter Cardiovasc Interv       Date:  2012-03-15       Impact factor: 2.692

5.  Catheter versus surgical ablation of atrial fibrillation after a failed initial pulmonary vein isolation procedure: a randomized controlled trial.

Authors:  Evgeny Pokushalov; Alexander Romanov; Dmitry Elesin; Alexander Bogachev-Prokophiev; Denis Losik; Sevda Bairamova; Alexander Karaskov; Jonathan S Steinberg
Journal:  J Cardiovasc Electrophysiol       Date:  2013-09-09

6.  Hemodynamic patterns of residual interatrial communication after transcatheter MitraClip repair.

Authors:  Gian Paolo Ussia; Valeria Cammalleri; Massimo Marchei; Domenico Sergi; Pasquale De Vico; Saverio Muscoli; Kunal Sarkar; Francesco Romeo
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2014-04       Impact factor: 2.160

7.  Ganglion Plexus Ablation in Advanced Atrial Fibrillation: The AFACT Study.

Authors:  Antoine H G Driessen; Wouter R Berger; Sébastien P J Krul; Nicoline W E van den Berg; Jolien Neefs; Femke R Piersma; Dean R P P Chan Pin Yin; Jonas S S G de Jong; WimJan P van Boven; Joris R de Groot
Journal:  J Am Coll Cardiol       Date:  2016-09-13       Impact factor: 24.094

8.  Atrial Septostomy to Treat Stiff Left Atrium Syndrome.

Authors:  Pranav Chandrashekar; Jae Yoon Park; Mohammad A Al-Hijji; Yogesh N V Reddy; Chad J Zack; Guy S Reeder; Robert F Rea; Barry A Borlaug
Journal:  Circ Heart Fail       Date:  2017-07       Impact factor: 8.790

9.  The incidence and long-term clinical outcome of iatrogenic atrial septal defects secondary to transseptal catheterization with a 12F transseptal sheath.

Authors:  Sheldon M Singh; Pamela S Douglas; Vivek Y Reddy
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-01-19

10.  Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.

Authors:  Jeffrey L Saver; John D Carroll; David E Thaler; Richard W Smalling; Lee A MacDonald; David S Marks; David L Tirschwell
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

View more
  1 in total

1.  Prospective evaluation of iatrogenic atrial septal defect after cryoballoon or radiofrequency catheter ablation of atrial fibrillation-"EVITA" study.

Authors:  Zsofia Nagy; Zsuzsanna Kis; Tamás Géczy; Andras Temesvari; Zoltan Som; Sarolta Borbas; Tamás Breuer; David Molnar; Csaba Foldesi; Attila Kardos
Journal:  J Interv Card Electrophysiol       Date:  2019-08-09       Impact factor: 1.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.